Investor Relations
Triphase in its growth phase and is expanding rapidly,Triphase is in the process of setting up a 9650 sqft state-of-art Nutraceuticals manufacturing plant in Mysore, Karnataka in India. The fully cGMP compliant facility once operational, will add capability to manufacture nutraceuticals (Prebiotics, Probiotics and Enzymes) of batch quantities ranging from 100 kg to 1.5 MT . A combination of the skilled core team, dedicated promoters with team of scientific and business advisors will usher Triphase as a significant player in the fast growing Probiotics market which is estimated at $30 Billion USD by year 2016 and $52 billion USD by 2020.If you would like to participate in Triphase's growth story as an investor, please drop an email to or